BTA biota holdings limited

resistance, page-17

  1. 275 Posts.
    "What is the chance of GSK manufacturing in China when in 2006 they licensed Simcere but did not provide the know-how to manufacture Relenza and Simcere said it will take a long time for approval?"

    Too much dwelling on the past. Comparing now to 2006 is crazy. Relenza was unloved by GSK in 2006. Now they love it, not as much biota shareholders, & not as much as they love their vaccines or facemasks or hand wipes, but love it they do.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.